The synergistic anticancer effect of the bromodomain inhibitor OTX015 and histone deacetylase 6 inhibitor WT-161 in osteosarcoma
Cancer Cell International,
Abstract Background Osteosarcoma (OS) is a tumour with a high malignancy level and a poor prognosis.